Our latest study on the the genetic modification of NK-92 cells for targeting tumor-associated antigens via TCR was published the European Journal of Immunology. This study was carried out in collaboration with Dr. Adil Doganay Duru’s lab in Nova Southeastern University, Florida.

You can reach the paper by following this link.